** Analysts at Morningstar of the opinion A2 Milk ATM.NZ has built a brand expected to protect economic profits for years to come
** A2's future growth relies heavily on further successful penetration of the Chinese infant formula market, which we estimate makes up the vast majority of earnings - Morningstar
** Investment research firm maintains fair value estimate at NZ$8.00/shr for the stock
** Morningstar expects Chinese-label business will more durably drive market share growth for the dairy processor without same reliance on resellers
** We forecast double-digit annual earnings growth over next five years - Morningstar
** Stock up 33.5% YTD, as of last close
(Reporting by Shivangi Lahiri in Bengaluru; editing by Giles Elgood)
((shivangi.lahiri@thomsonreuters.com))